citris-uc.org
Foundry alum partners with Genentech for nonviral gene therapy delivery - CITRIS and the Banatao Institute
The biotech giant will license GenEdit’s NanoGalaxy platform in a $15 million agreement to enhance autoimmune disease medications.
Anna Linn
Post to Tumblr